New and veteran faculty mingled over cocktails at the Met’s Great Hall Balcony Bar.
On Thursday, July 28, the second annual Faculty Retreat took place at the Metropolitan Museum of Art. Over the course of the day, 17 new faculty members introduced themselves to the department and presented their current research, followed by a cocktail reception.
Keren Bachi, PhD, LCSW, Assistant Professor of Psychiatry, Assistant Professor of Department of Environmental Medicine and Public Health, presented “Neuroimmune and Psychosocial Pathways to Disease and Recovery in Drug Addiction.” Dr. Bachi received her PhD in Social Welfare from the City University of New York, and completed her postdoctoral fellowship training with the Neuroimaging of Addiction and Related Conditions Research Program.
Veerle Bergink, MD, PhD, Professor of Psychiatry, Professor of Obstetrics, Gynecology and Reproductive Science, Director of Women’s Mental Health Program, presented “Perinatal Psychiatry Research: Between a Rock and a Hard Place.” Dr. Bergink received her MD from the University Groningen, trained at OLVG West and University Hospital Utrecht, and completed her PhD at Erasmus University Rotterdam (all in the Netherlands).
Alexander Charney, MD, PhD, Assistant Professor of Psychiatry, Assistant Professor of Genetics, Assistant Professor of Neurosurgery, presented “Advancing the Treatment of Mental Illness Through Multiscale Neuroscience.” Dr. Charney received his MD, PhD and residency in psychiatry at the Icahn School of Medicine at Mount Sinai.
Cheryl Corcoran, MD, Associate Professor of Psychiatry, Program Leader in Psychosis Risk, Staff Physician, The James J. Peters VA Medical Center (Bronx VA), presented “Language and Psychosis Risk.” Dr. Corcoran received her MD from Harvard University, trained at Cambridge Hospital, and completed a fellowship at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Silvia De Rubeis, PhD, Assistant Professor of Psychiatry, presented “A Translational Approach to DDX3X Syndrome: From Basic Science to Clinical Studies.” Dr. De Rubeis received her PhD in cellular and molecular biology from the University of Rome “Tor Vergata” (Italy), and completed postdoctoral fellowships at the VIB Center for Human Genetics (Belgium), and the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai.
Gaelle Doucet, PhD, Assistant Professor of Psychiatry, presented “Role of Resting-State FMRI in Vulnerability and Resilience to Psychotic Disorders.” Dr. Doucet completed a PhD in cognitive neuroscience from the University of Caen (France), a postdoctoral fellowship at Thomas Jefferson University, and postdoctoral fellowship at the Icahn School of Medicine at Mount Sinai.
Elodie Drapeau, PhD, Assistant Professor of Psychiatry, presented “iPSC Modeling of Rare Neurodevelopmental Disorders.” Dr. Drapeau received her PhD in neurosciences and neuropharmacology at the University of Bordeaux (France) and completed her first postdoctoral training at Columbia University and completed her second postdoctoral training at the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai.
Martijn Figee, MD, PhD, Associate Professor of Psychiatry, Director of Interventional Psychiatry Program, presented “Optimizing Neuromodulation of Circuits for Mood, Motivation, and Motor Control.” Dr. Figee received his MD and PhD, and completed his residency at the University of Amsterdam (Netherlands).
Xiaosi GU, PhD, Assistant Professor of Psychiatry, presented “Computational Psychiatry: Promises and Challenges.” Dr. Gu completed her PhD in neuroscience at the Icahn School of Medicine at Mount Sinai, and completed her postdoctoral training in computational psychiatry at Virginia Tech and the University College London.
Hala Harony-Nicolas, PhD, Assistant Professor of Psychiatry and Neuroscience, presented “Neural Circuits and Brain System Alterations Underlying Social Deficits.” Dr. Harony-Nicolas received her PhD in molecular biology at the Technion Institute (Israel), completed her first postdoctoral training in molecular neurobiology at University of Haifa (Israel), and completed her second postdoctoral training at the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai.
David Kimhy, PhD, Associate Professor of Psychiatry, Program Leader in New Interventions in Schizophrenia, Director of Experimental Psychopathology Lab, presented “Novel Cognitive and Behavioral Interventions for People with Psychosis and At-Risk States.” Dr. Kimhy received his PhD from Long Island University, trained at Long Island Jewish Medical Center, and was a postdoctoral fellow in schizophrenia research at Columbia University.
Dolores Malaspina, MD, MS, MSPH, Professor of Psychiatry, Professor of Neuroscience, Professor of Genetics, Director of the Psychosis Program, presented “A Behavioral Ecology Approach to Schizophrenia.” Dr. Malaspina completed her residency and fellowship training at the New York State Psychiatric Institute and Columbia University; she also completed an MPH in epidemiology. She joined the Icahn School of Medicine at Mount Sinai from New York University, where she had served as the Chair of Psychiatry.
Helen S. Mayberg, MD, Professor of Neurology, Professor of Neuroscience, Professor of Neurosurgery, Professor of Neurotherapeutics, Professor of Psychiatry, Director of Center for Advanced Circuit Therapeutics, presented “Evolution of the Center for Advanced Circuit Therapeutics.” Dr. Mayberg received her MD from the University of Southern California, trained at the Neurological Institute of New York at Columbia University, and was a postdoctoral fellow in nuclear medicine at Johns Hopkins Medicine.
Julie Spicer, PhD, Assistant Professor of Psychiatry, presented “The Role of Maternal Prenatal Stress in Mother-Infant Outcomes: A Health Neuroscience Approach.” Dr. Spicer completed her PhD in psychology with a specialization in cognitive affective neuroscience from Columbia University, and postdoctoral training in behavioral medicine at Columbia University Medical Center.
An-li Wang, PhD, Assistant Professor of Psychiatry, presented “Neuroimaging of the Public Health and Clinical Interventions in Opioid Addiction.” Dr. Wang completed her PhD in human electrophysiology and pain at the University of Oxford, and her postdoctoral training in neuroimaging and addiction at the University of Pennsylvania.
Anna Zilverstand, PhD, Assistant Professor of Psychiatry, presented “Neuroscience-Based Personalized Interventions for Human Drug Addiction.” Dr. Zilverstand completed her PhD in cognitive neuroscience at Maastricht University (Netherlands), and was a postdoctoral fellow at the Neuropsychoimaging of Addiction and Related Conditions Research Program at the Icahn School of Medicine at Mount Sinai.